FDA Warns About Stroke, Artery Tear Risk With Multiple Sclerosis Drug

FDA Warns About Stroke, Artery Tear Risk With Multiple Sclerosis Drug

The FDA is warning that it has received a small number of serious reports of stroke and tears in the lining of head and neck arteries in patients taking the multiple sclerosis (MS) drug Lemtrada (alemtuzumab).

The agency has received reports of 14 such cases since Lemtrada was approved for MS in 2014. Most of the serious effects occurred within one day of receiving the drug. The problems “can lead to permanent disability and even death,” according to the FDA.

As a result, the new risks will be added to Lemtrada’s drug label with the stroke risk added to an existing “black box” warning, the agency’s most serious. Alemtuzumab is also approved under the name Campath as a leukemia treatment, and its label will also get the same changes.

The FDA says that patients should seek emergency treatment immediately if they experience signs or symptoms of artery lining tears or stroke, such as sudden numbness or weakness in the face, arms or legs; sudden confusion or trouble speaking; sudden vision problems; sudden difficulty walking or maintaining balance; and sudden severe head or neck pain.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?

No votes so far! Be the first to rate this post.


Latest News

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

Flouride, PPIs, Breast Density and Prostate Cancer

Flouride, PPIs, Breast Density and Prostate Cancer

Startling news about fluoride, a study encourages more limites use of PPIs, does knowing the density of your breasts matter, and vegetables aren’t helpful in warding off prostate cancer (darn).  Be Well.  Fluoride and Pregnancy The medical community was shocked at the conclusions of two new studies on fluoride’s effect…

  • Advertisement